BioLife Solutions
BLFS
164 hedge funds and large institutions have $1B invested in BioLife Solutions in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 56 increasing their positions, 49 reducing their positions, and 14 closing their positions.
1,876% more call options, than puts
Call options by funds: $336K | Put options by funds: $17K
114% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 14
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
22% more capital invested
Capital invested by funds: $823M → $1B (+$177M)
14% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 49
10% more funds holding
Funds holding: 149 → 164 (+15)
3.39% more ownership
Funds ownership: 98.03% → 101.42% (+3.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$39.7M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$9.13M |
| 3 |
MOACM
Mutual of America Capital Management
New York
|
+$7.78M |
| 4 |
RA
Royce & Associates
New York
|
+$7.71M |
| 5 |
Rockefeller Capital Management
New York
|
+$6.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$15.6M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.01M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$6.39M |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.5M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$3.01M |
BLFS Hedge Fund Activity: Q2 2024 in Review
164 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2024, worth a combined $1B — up 22% from $823M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new BLFS positions and 14 closed out — a net gain of 16 holders — while 56 added to existing stakes and 49 trimmed.
The largest buyer was Invesco, adding an estimated $39.7M. The largest seller was Millennium Management, cutting an estimated $15.6M.
- 164 institutional investors held BioLife Solutions (BLFS) as of Q2 2024, up from 149 in Q1 2024.
- Funds reported $1B of BioLife Solutions stock for Q2 2024, up 22% quarter-over-quarter.
- 30 funds opened new BioLife Solutions positions in Q2 2024 and 14 closed out, a net change of +16 holders.
- The largest BioLife Solutions buyer in Q2 2024 was Invesco, an estimated $39.7M added.
- The largest BioLife Solutions seller in Q2 2024 was Millennium Management, an estimated $15.6M sold.
Based on aggregated 13F filings for Q2 2024.